Oncology Institute, Inc.

TOI Nasdaq CIK: 0001799191

Company Information

Industry Services-Offices & Clinics of Doctors of Medicine
SIC Code 8011
Entity Type operating
SEC Category Accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 18000 STUDEBAKER RD, CERRITOS, CA, 90703
Mailing Address 18000 STUDEBAKER RD, CERRITOS, CA, 90703
Phone 562-735-3226
Fiscal Year End 1231
EIN 843562323

Financial Overview

FY2025

$-0.71
EPS

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report March 30, 2026 View on SEC
4 Insider stock transaction report March 27, 2026 View on SEC
4 Insider stock transaction report March 25, 2026 View on SEC
4 Insider stock transaction report March 23, 2026 View on SEC
3 Initial insider ownership report March 20, 2026 View on SEC
4 Insider stock transaction report March 18, 2026 View on SEC
4 Insider stock transaction report March 18, 2026 View on SEC
4 Insider stock transaction report March 18, 2026 View on SEC
4 Insider stock transaction report March 17, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment March 16, 2026 View on SEC

Annual Reports

10-K March 12, 2026
  • Strong revenue growth (17.6% YoY) to $1.4 billion and a significant return to net profitability ($168.75 million) in 2025.
  • Successful capital raises totaling $55 million and a strategic reduction of convertible debt from $120 million to $100 million.
View Analysis

Insider Trading

STRONG BUY 3 insiders 9 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 8011)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.